Publication | Open Access
Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma
91
Citations
36
References
2012
Year
MedicinePharmacologyPathologyPhase Ii StudyAnti-cancer AgentCancer TreatmentMetastatic Nasopharyngeal CarcinomaOncologyRadiation OncologyMolecular Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1